Cargando…

Non-diabetic use of liraglutide

Detalles Bibliográficos
Autor principal:	Verma, Abhyudaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475931/ https://www.ncbi.nlm.nih.gov/pubmed/23087891 http://dx.doi.org/10.4103/2230-8210.100698

Ejemplares similares

Monotherapy with liraglutide – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus
por: Wilbrink, Francis J, et al.
Publicado: (2018)

An accidental liraglutide overdose: case report
por: Elmehdawi, Rafik R., et al.
Publicado: (2014)

Recent update on biological activities and pharmacological actions of liraglutide
por: Tiwari, Juhi, et al.
Publicado: (2017)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures
por: Gupta, Gaurav, et al.
Publicado: (2017)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β‐cell function and the achievement of the HbA1c target 1 year after initiation
por: Usui, Ryota, et al.
Publicado: (2018)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
por: Okada, Kenta, et al.
Publicado: (2014)

Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease
por: Verma, Subodh, et al.
Publicado: (2022)

Effect of COVID 19 Second Wave on Children with type 1 Diabetes Mellitus in India
por: Verma, Anjali, et al.
Publicado: (2021)

Controlled release of liraglutide using thermogelling polymers in treatment of diabetes
por: Chen, Yipei, et al.
Publicado: (2016)

Careful Non-operative Management with Surveillance of Acute Appendicitis During COVID-19 Pandemic
por: Verma, Surender, et al.
Publicado: (2020)

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes
por: Courrèges, J-P, et al.
Publicado: (2008)

Comment on “The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats”
por: Verma, Hitesh, et al.
Publicado: (2015)

Acute hyperkalemia induced by hyperglycemia in non-diabetic patient
por: Park, Sun Young, et al.
Publicado: (2011)

Comment on “Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial”
por: Verma, Hitesh, et al.
Publicado: (2015)

Potential of liraglutide in the treatment of patients with type 2 diabetes
por: Deacon, Carolyn F
Publicado: (2009)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato, Mauro, et al.
Publicado: (2014)

Regarding comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population
por: Wells, Kevin Michael, et al.
Publicado: (2013)

A Different Effect of an Orexin Receptor Antagonist on Metabolic Parameters Between Diabetic Patients and Non-Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

Coadministration of Liraglutide With Tacrolimus in Kidney Transplant Recipients: A Case Series
por: Pinelli, Nicole R., et al.
Publicado: (2013)

Comment on “An observational pilot study using a purified reconstituted bilayer matrix to treat non‐healing diabetic foot ulcers”
por: Armstrong, David G.
Publicado: (2020)

Comment on “An observational pilot study using a purified reconstituted bilayer matrix to treat non‐healing diabetic foot ulcers”
por: Isaac, Adam L., et al.
Publicado: (2020)

DAPA-HF study: Are the benefits uniform across non-diabetic subgroups
por: Pareek, Anil, et al.
Publicado: (2020)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Query to the author of ‘comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population’
por: Gupta, Sanjiv Kumar, et al.
Publicado: (2013)

Impact of social media use (SMU) on mental health during COVID-19 pandemic
por: Verma, Kalpana
Publicado: (2021)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
por: Minze, Molly G, et al.
Publicado: (2016)

Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide
por: Ghosh, Aneesh
Publicado: (2021)

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022)

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
por: Lind, Marcus, et al.
Publicado: (2015)

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
por: Nauck, Michael, et al.
Publicado: (2009)

Evaluation of the efficacy of low‐dose liraglutide in weight control among Taiwanese non‐diabetes patients
por: Chou, Chien‐An, et al.
Publicado: (2020)

The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis
por: Zhang, Pei, et al.
Publicado: (2019)

Comparative Risk of Type 2 Diabetes Mellitus Among Vegetarians and Non-Vegetarians
por: Sarwar Zaman, Gaffar, et al.
Publicado: (2010)

Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
por: Parlett, Lauren, et al.
Publicado: (2021)

Addition of metformin to non‐small‐cell lung cancer patients with or without diabetes
por: Chen, Hua‐Fen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6d3bnpd7plipf69urifree99gn